299 related articles for article (PubMed ID: 26774138)
1. Role of pericytes in angiogenesis: focus on cancer angiogenesis and anti-angiogenic therapy.
Chen Z; Xu XH; Hu J
Neoplasma; 2016; 63(2):173-82. PubMed ID: 26774138
[TBL] [Abstract][Full Text] [Related]
2. Pericytes and vessel maturation during tumor angiogenesis and metastasis.
Raza A; Franklin MJ; Dudek AZ
Am J Hematol; 2010 Aug; 85(8):593-8. PubMed ID: 20540157
[TBL] [Abstract][Full Text] [Related]
3. Weibel-Palade Bodies Orchestrate Pericytes During Angiogenesis.
Cossutta M; Darche M; Carpentier G; Houppe C; Ponzo M; Raineri F; Vallée B; Gilles ME; Villain D; Picard E; Casari C; Denis C; Paques M; Courty J; Cascone I
Arterioscler Thromb Vasc Biol; 2019 Sep; 39(9):1843-1858. PubMed ID: 31315435
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of pericyte recruitment in tumour angiogenesis: a new role for metalloproteinases.
Chantrain CF; Henriet P; Jodele S; Emonard H; Feron O; Courtoy PJ; DeClerck YA; Marbaix E
Eur J Cancer; 2006 Feb; 42(3):310-8. PubMed ID: 16406506
[TBL] [Abstract][Full Text] [Related]
5. Pericyte signaling via soluble guanylate cyclase shapes the vascular niche and microenvironment of tumors.
Zhu J; Yang W; Ma J; He H; Liu Z; Zhu X; He X; He J; Chen Z; Jin X; Wang X; He K; Wei W; Hu J
EMBO J; 2024 Apr; 43(8):1519-1544. PubMed ID: 38528180
[TBL] [Abstract][Full Text] [Related]
6. Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms.
Erber R; Thurnher A; Katsen AD; Groth G; Kerger H; Hammes HP; Menger MD; Ullrich A; Vajkoczy P
FASEB J; 2004 Feb; 18(2):338-40. PubMed ID: 14657001
[TBL] [Abstract][Full Text] [Related]
7. Pericytes: a double-edged sword in cancer therapy.
Meng MB; Zaorsky NG; Deng L; Wang HH; Chao J; Zhao LJ; Yuan ZY; Ping W
Future Oncol; 2015; 11(1):169-79. PubMed ID: 25143028
[TBL] [Abstract][Full Text] [Related]
8. Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors.
Abramsson A; Lindblom P; Betsholtz C
J Clin Invest; 2003 Oct; 112(8):1142-51. PubMed ID: 14561699
[TBL] [Abstract][Full Text] [Related]
9. Pericyte dynamics during angiogenesis: new insights from new identities.
Stapor PC; Sweat RS; Dashti DC; Betancourt AM; Murfee WL
J Vasc Res; 2014; 51(3):163-74. PubMed ID: 24853910
[TBL] [Abstract][Full Text] [Related]
10. VEGFR2-dependent angiogenic capacity of pericyte-like dental pulp stem cells.
Janebodin K; Zeng Y; Buranaphatthana W; Ieronimakis N; Reyes M
J Dent Res; 2013 Jun; 92(6):524-31. PubMed ID: 23609159
[TBL] [Abstract][Full Text] [Related]
11. Targeting pericytes for angiogenic therapies.
Kelly-Goss MR; Sweat RS; Stapor PC; Peirce SM; Murfee WL
Microcirculation; 2014 May; 21(4):345-57. PubMed ID: 24267154
[TBL] [Abstract][Full Text] [Related]
12. Pericyte coverage decreases invasion of tumour cells into blood vessels in prostate cancer xenografts.
Welén K; Jennbacken K; Tesan T; Damber JE
Prostate Cancer Prostatic Dis; 2009; 12(1):41-6. PubMed ID: 18521102
[TBL] [Abstract][Full Text] [Related]
13. Increased pericyte coverage mediated by endothelial-derived fibroblast growth factor-2 and interleukin-6 is a source of smooth muscle-like cells in pulmonary hypertension.
Ricard N; Tu L; Le Hiress M; Huertas A; Phan C; Thuillet R; Sattler C; Fadel E; Seferian A; Montani D; Dorfmüller P; Humbert M; Guignabert C
Circulation; 2014 Apr; 129(15):1586-97. PubMed ID: 24481949
[TBL] [Abstract][Full Text] [Related]
14. The antiangiogenic 16K prolactin impairs functional tumor neovascularization by inhibiting vessel maturation.
Nguyen NQ; Castermans K; Berndt S; Herkenne S; Tabruyn SP; Blacher S; Lion M; Noel A; Martial JA; Struman I
PLoS One; 2011; 6(11):e27318. PubMed ID: 22087289
[TBL] [Abstract][Full Text] [Related]
15. Early contribution of pericytes to angiogenic sprouting and tube formation.
Ozerdem U; Stallcup WB
Angiogenesis; 2003; 6(3):241-9. PubMed ID: 15041800
[TBL] [Abstract][Full Text] [Related]
16. Establishment of a 3D model of tumor-driven angiogenesis to study the effects of anti-angiogenic drugs on pericyte recruitment.
Qiu Y; Wang N; Guo T; Liu S; Tang X; Zhong Z; Chen Q; Wu H; Li X; Wang J; Zhang S; Ou Y; Wang B; Ma K; Gu W; Cao J; Chen H; Duan Y
Biomater Sci; 2021 Sep; 9(18):6064-6085. PubMed ID: 34136892
[TBL] [Abstract][Full Text] [Related]
17. PDGFR-β inhibitor slows tumor growth but increases metastasis in combined radiotherapy and Endostar therapy.
Yin L; He J; Xue J; Na F; Tong R; Wang J; Gao H; Tang F; Mo X; Deng L; Lu Y
Biomed Pharmacother; 2018 Mar; 99():615-621. PubMed ID: 29653486
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies.
Eberhard A; Kahlert S; Goede V; Hemmerlein B; Plate KH; Augustin HG
Cancer Res; 2000 Mar; 60(5):1388-93. PubMed ID: 10728704
[TBL] [Abstract][Full Text] [Related]
19. Pericyte chemomechanics and the angiogenic switch: insights into the pathogenesis of proliferative diabetic retinopathy?
Durham JT; Dulmovits BM; Cronk SM; Sheets AR; Herman IM
Invest Ophthalmol Vis Sci; 2015 Jun; 56(6):3441-59. PubMed ID: 26030100
[TBL] [Abstract][Full Text] [Related]
20. The complex mural cell: pericyte function in health and disease.
van Dijk CG; Nieuweboer FE; Pei JY; Xu YJ; Burgisser P; van Mulligen E; el Azzouzi H; Duncker DJ; Verhaar MC; Cheng C
Int J Cardiol; 2015; 190():75-89. PubMed ID: 25918055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
